Skip to main content
. Author manuscript; available in PMC: 2008 Apr 15.
Published in final edited form as: Bioorg Med Chem Lett. 2006 Oct 4;17(8):2380–2384. doi: 10.1016/j.bmcl.2006.09.093

Scheme 2.

Scheme 2

Reagents and conditions: (i) for 8, 3,3′-diamino-N-methyldipropylamine; for 9, N-(3-aminopropyl)-1,3-propanediamine; for 10, 1,4-bis(3-aminopropyl)piperazine.20